NASDAQ:ARAY - Accuray Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$4.8750 -0.03 (-0.61 %)
(As of 05/23/2018 09:36 AM ET)
Previous Close$4.90
Today's Range$4.85 - $4.90
52-Week Range$3.60 - $6.15
Volume12,012 shs
Average Volume443,911 shs
Market Capitalization$428.19 million
P/E Ratio-13.54
Dividend YieldN/A
Beta1.75

About Accuray (NASDAQ:ARAY)

Accuray logoAccuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. It also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. The company markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors and sales agents in Europe, Japan and other countries of Asia, South America, and internationally to hospitals and stand-alone treatment facilities. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.

Receive ARAY News and Ratings via Email

Sign-up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ARAY
CUSIP00439710
Phone408-716-4600

Debt

Debt-to-Equity Ratio3.00
Current Ratio1.62
Quick Ratio0.97

Price-To-Earnings

Trailing P/E Ratio-13.54
Forward P/E Ratio-16.81
P/E GrowthN/A

Sales & Book Value

Annual Sales$383.41 million
Price / Sales1.09
Cash FlowN/A
Price / CashN/A
Book Value$0.52 per share
Price / Book9.38

Profitability

EPS (Most Recent Fiscal Year)($0.36)
Net Income$-29,570,000.00
Net Margins-7.00%
Return on Equity-52.91%
Return on Assets-6.25%

Miscellaneous

Employees944
Outstanding Shares85,640,000

Accuray (NASDAQ:ARAY) Frequently Asked Questions

What is Accuray's stock symbol?

Accuray trades on the NASDAQ under the ticker symbol "ARAY."

How were Accuray's earnings last quarter?

Accuray Incorporated (NASDAQ:ARAY) announced its earnings results on Monday, April, 30th. The medical equipment provider reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by $0.05. The medical equipment provider earned $99.83 million during the quarter, compared to analysts' expectations of $98.18 million. Accuray had a negative net margin of 7.00% and a negative return on equity of 52.91%. View Accuray's Earnings History.

When is Accuray's next earnings date?

Accuray is scheduled to release their next quarterly earnings announcement on Tuesday, August, 28th 2018. View Earnings Estimates for Accuray.

What price target have analysts set for ARAY?

6 analysts have issued 12 month target prices for Accuray's shares. Their forecasts range from $6.00 to $10.00. On average, they anticipate Accuray's share price to reach $7.40 in the next year. View Analyst Ratings for Accuray.

Are investors shorting Accuray?

Accuray saw a decrease in short interest during the month of April. As of April 30th, there was short interest totalling 3,610,718 shares, a decrease of 25.4% from the April 13th total of 4,843,303 shares. Based on an average trading volume of 388,878 shares, the days-to-cover ratio is presently 9.3 days. Approximately 4.4% of the shares of the company are sold short.

Who are some of Accuray's key competitors?

Who are Accuray's key executives?

Accuray's management team includes the folowing people:
  • Mr. Joshua H. Levine, Pres, Chief Exec. Officer & Director (Age 60)
  • Mr. Kevin Waters, Sr. VP & CFO (Age 41)
  • Mr. Andrew Kirkpatrick, Sr. VP of Global Operations (Age 55)
  • Ms. Alaleh Nouri, Sr. VP, Gen. Counsel & Corp. Sec. (Age 39)
  • Mr. Lionel Hadjadjeba, Sr. VP & Chief Commercial Officer (Age 59)

Has Accuray been receiving favorable news coverage?

Media coverage about ARAY stock has been trending somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Accuray earned a news impact score of 0.12 on Accern's scale. They also gave news articles about the medical equipment provider an impact score of 46.23 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are Accuray's major shareholders?

Accuray's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.45%), Neuberger Berman Group LLC (5.33%), Russell Investments Group Ltd. (5.18%), Heartland Advisors Inc. (3.71%), Boston Partners (3.07%) and Dimensional Fund Advisors LP (2.19%). Company insiders that own Accuray stock include Alaleh Nouri, Joshua Levine, Kelly Londy and Kevin Waters. View Institutional Ownership Trends for Accuray.

Which institutional investors are selling Accuray stock?

ARAY stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Millennium Management LLC, Spark Investment Management LLC, Heartland Advisors Inc., Granite Investment Partners LLC, Neuberger Berman Group LLC, UBS Group AG and Lapides Asset Management LLC. Company insiders that have sold Accuray company stock in the last year include Alaleh Nouri, Joshua Levine, Kelly Londy and Kevin Waters. View Insider Buying and Selling for Accuray.

Which institutional investors are buying Accuray stock?

ARAY stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Legal & General Group Plc, BlackRock Inc., Global X Management Co. LLC, Dimensional Fund Advisors LP, Boston Partners, Mackay Shields LLC and Algert Global LLC. View Insider Buying and Selling for Accuray.

How do I buy shares of Accuray?

Shares of ARAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Accuray's stock price today?

One share of ARAY stock can currently be purchased for approximately $4.8750.

How big of a company is Accuray?

Accuray has a market capitalization of $428.19 million and generates $383.41 million in revenue each year. The medical equipment provider earns $-29,570,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis. Accuray employs 944 workers across the globe.

How can I contact Accuray?

Accuray's mailing address is 1310 CHESAPEAKE TERRACE, SUNNYVALE CA, 94089. The medical equipment provider can be reached via phone at 408-716-4600 or via email at [email protected]


MarketBeat Community Rating for Accuray (ARAY)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  233 (Vote Outperform)
Underperform Votes:  190 (Vote Underperform)
Total Votes:  423
MarketBeat's community ratings are surveys of what our community members think about Accuray and other stocks. Vote "Outperform" if you believe ARAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Accuray (NASDAQ:ARAY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Accuray in the last 12 months. Their average twelve-month price target is $7.40, suggesting that the stock has a possible upside of 51.79%. The high price target for ARAY is $10.00 and the low price target for ARAY is $6.00. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.332.332.432.50
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.40$7.40$7.40$6.60
Price Target Upside: 51.79% upside51.02% upside35.78% upside45.05% upside

Accuray (NASDAQ:ARAY) Consensus Price Target History

Price Target History for Accuray (NASDAQ:ARAY)

Accuray (NASDAQ:ARAY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/10/2018Royal Bank of CanadaSet Price TargetHold$6.00HighView Rating Details
12/13/2017JPMorgan ChaseDowngradeNeutral ➝ Underweight$6.00HighView Rating Details
11/30/2017Lake Street CapitalInitiated CoverageBuy ➝ Buy$10.00HighView Rating Details
10/27/2017CowenReiterated RatingBuy$9.00N/AView Rating Details
8/24/2017BTIG ResearchReiterated RatingHoldMediumView Rating Details
8/23/2017Jefferies GroupLower Price TargetBuy$7.00 ➝ $6.00LowView Rating Details
3/21/2017AegisReiterated RatingBuyMediumView Rating Details
8/18/2016Morgan StanleySet Price TargetHold$8.00N/AView Rating Details
(Data available from 5/23/2016 forward)

Earnings

Accuray (NASDAQ:ARAY) Earnings History and Estimates Chart

Earnings by Quarter for Accuray (NASDAQ:ARAY)

Accuray (NASDAQ:ARAY) Earnings Estimates

2018 EPS Consensus Estimate: ($0.20)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.04)($0.04)($0.04)
Q2 20181($0.10)($0.10)($0.10)
Q3 20181($0.04)($0.04)($0.04)
Q4 20181($0.02)($0.02)($0.02)

Accuray (NASDAQ ARAY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/28/2018        
4/30/2018Q3 2018($0.05)($0.10)$98.18 million$99.83 millionViewListenView Earnings Details
1/23/2018Q2 18($0.11)($0.06)$90.31 million$100.33 millionViewListenView Earnings Details
10/24/2017Q1 2018($0.09)($0.07)$88.26 million$91.00 millionViewN/AView Earnings Details
8/22/20176/30/2017($0.01)($0.06)$112.00 million$112.09 millionViewN/AView Earnings Details
4/27/2017Q3 2017$0.0120($0.06)$110.23 million$97.31 millionViewN/AView Earnings Details
1/31/2017Q217($0.09)($0.11)$93.74 million$87.50 millionViewListenView Earnings Details
10/27/2016Q117($0.10)($0.12)$37.34 million$86.50 millionViewListenView Earnings Details
8/17/2016Q316($0.07)($0.09)$98.97 million$95.00 millionViewListenView Earnings Details
4/26/2016Q316($0.06)$0.01$102.79 million$105.30 millionViewListenView Earnings Details
1/28/2016Q216($0.08)($0.08)$101.15 million$108.90 millionViewListenView Earnings Details
10/29/2015Q116($0.14)($0.12)$88.60 million$89.60 millionViewListenView Earnings Details
8/20/2015Q415($0.04)($0.07)$102.41 million$101.80 millionViewListenView Earnings Details
4/30/2015Q315($0.06)($0.04)$102.72 million$97.50 millionViewListenView Earnings Details
1/27/2015Q215($0.08)($0.13)$98.87 million$98.20 millionViewListenView Earnings Details
10/29/2014Q115($0.13)($0.28)$88.90 million$82.40 millionViewListenView Earnings Details
8/21/2014Q414($0.07)($0.13)$92.23 million$102.00 millionViewListenView Earnings Details
4/30/2014Q314($0.16)($0.06)$82.00 million$97.10 millionViewListenView Earnings Details
1/30/2014Q214($0.20)($0.07)$80.20 million$93.60 millionViewListenView Earnings Details
11/7/2013Q114($0.20)($0.21)$79.67 million$76.60 millionViewListenView Earnings Details
8/27/2013Q4 2013($0.20)($0.20)$82.29 million$84.90 millionViewListenView Earnings Details
5/7/2013Q3 2013($0.22)($0.37)$77.97 million$70.55 millionViewListenView Earnings Details
2/6/2013Q2 2013($0.33)($0.30)$74.23 million$77.80 millionViewListenView Earnings Details
11/7/2012Q113($0.22)($0.23)$85.41 million$83.00 millionViewN/AView Earnings Details
9/6/2012Q412($0.12)($0.20)$106.92 million$100.50 millionViewN/AView Earnings Details
5/8/2012($0.14)($0.21)ViewN/AView Earnings Details
2/8/2012Q2 2012($0.19)($0.10)ViewN/AView Earnings Details
11/8/2011($0.29)($0.38)ViewN/AView Earnings Details
9/19/2011$0.02($0.40)ViewN/AView Earnings Details
5/5/2011$0.04($0.02)ViewN/AView Earnings Details
1/27/2011($0.01)$0.07ViewN/AView Earnings Details
11/8/2010Q1 2011($0.07)($0.08)ViewN/AView Earnings Details
8/31/2010Q4 2010$0.05$0.08ViewN/AView Earnings Details
5/6/2010Q3 2010$0.01$0.04ViewN/AView Earnings Details
2/4/2010Q2 2010($0.01)($0.02)ViewN/AView Earnings Details
10/29/2009Q1 2010($0.03)($0.06)ViewN/AView Earnings Details
8/24/2009Q4 2009$0.03$0.02ViewN/AView Earnings Details
5/5/2009Q3 2009$0.02$0.05ViewN/AView Earnings Details
1/29/2009Q2 2009$0.02$0.02ViewN/AView Earnings Details
12/18/2008Q1 2009$0.02($0.06)ViewN/AView Earnings Details
4/29/2008Q3 2008$0.05$0.01ViewN/AView Earnings Details
1/30/2008Q2 2008$0.12$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Accuray (NASDAQ:ARAY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Accuray (NASDAQ ARAY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.90%
Institutional Ownership Percentage: 83.79%
Insider Trading History for Accuray (NASDAQ:ARAY)
Institutional Ownership by Quarter for Accuray (NASDAQ:ARAY)

Accuray (NASDAQ ARAY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/3/2018Alaleh NouriSVPSell2,585$4.65$12,020.25204,483View SEC Filing  
4/3/2018Joshua LevineCEOSell8,675$4.65$40,338.751,426,753View SEC Filing  
4/3/2018Kevin WatersCFOSell2,997$4.65$13,936.05328,260View SEC Filing  
12/1/2017Alaleh NouriSVPSell2,166$4.86$10,526.76207,068View SEC Filing  
12/1/2017Joshua LevineCEOSell17,093$4.86$83,071.981,435,428View SEC Filing  
12/1/2017Kevin WatersCFOSell7,154$5.06$36,199.24335,087View SEC Filing  
10/4/2017Kelly LondyCOOSell99,136$4.24$420,336.64View SEC Filing  
11/9/2015Joshua LevineCEOBuy50,000$7.12$356,000.001,115,830View SEC Filing  
2/2/2015Alaleh NouriSVPSell5,164$7.38$38,110.32View SEC Filing  
11/30/2014Alaleh NouriSVPSell268$6.62$1,774.16View SEC Filing  
11/30/2014Kelly LondyEVPSell2,273$6.62$15,047.26View SEC Filing  
11/3/2014Joshua LevineCEOBuy100,000$6.34$634,000.00View SEC Filing  
5/6/2014Joshua LevineCEOBuy50,000$8.15$407,500.00531,210View SEC Filing  
2/4/2014Richard PettingillDirectorBuy9,795$10.33$101,182.3543,940View SEC Filing  
12/4/2013Jack GoldsteinDirectorSell7,000$7.70$53,900.0066,237View SEC Filing  
12/3/2013Elizabeth DavilaDirectorSell8,000$7.74$61,920.0077,137View SEC Filing  
9/4/2013Darren J MillikenSVPSell11,002$6.53$71,843.06View SEC Filing  
3/5/2013Dennis L WingerDirectorBuy20,000$4.30$86,000.00View SEC Filing  
2/13/2013Joshua LevineCEOBuy100,000$4.38$438,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Accuray (NASDAQ ARAY) News Headlines

Source:
DateHeadline
Accuray CyberKnife® Customer Achieves Top Score in Multiple Brain Metastases TROG 2018 Treatment Plan StudyAccuray CyberKnife® Customer Achieves Top Score in Multiple Brain Metastases TROG 2018 Treatment Plan Study
finance.yahoo.com - May 22 at 8:56 AM
 Brokerages Anticipate Accuray Incorporated (ARAY) Will Post Earnings of -$0.02 Per Share Brokerages Anticipate Accuray Incorporated (ARAY) Will Post Earnings of -$0.02 Per Share
www.americanbankingnews.com - May 22 at 1:16 AM
Accuray (ARAY) Upgraded to "Hold" at ValuEngineAccuray (ARAY) Upgraded to "Hold" at ValuEngine
www.americanbankingnews.com - May 18 at 11:48 PM
Factors of Influence in 2018, Key Indicators and Opportunity within Accuray, Torchmark, Carlisle Companies, CVR ...Factors of Influence in 2018, Key Indicators and Opportunity within Accuray, Torchmark, Carlisle Companies, CVR ...
globenewswire.com - May 15 at 9:31 AM
Accuray Unveils New Company Website Reflecting Industry-Leading Patient-First Cancer Treatment Innovation and CareAccuray Unveils New Company Website Reflecting Industry-Leading Patient-First Cancer Treatment Innovation and Care
www.prnewswire.com - May 15 at 9:31 AM
Accuray Incorporated (ARAY) Sees Significant Decline in Short InterestAccuray Incorporated (ARAY) Sees Significant Decline in Short Interest
www.americanbankingnews.com - May 14 at 1:33 AM
Accuray Incorporated (ARAY) Receives Consensus Rating of "Hold" from AnalystsAccuray Incorporated (ARAY) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - May 13 at 5:35 AM
Accuray (ARAY) Rating Increased to Hold at BidaskClubAccuray (ARAY) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - May 12 at 5:01 PM
Mercy Advances Cancer Care in Missouri with Multi-System, Multi-Hospital Agreement for Accuray Radiation Therapy ...Mercy Advances Cancer Care in Missouri with Multi-System, Multi-Hospital Agreement for Accuray Radiation Therapy ...
www.prnewswire.com - May 9 at 9:08 AM
 Analysts Anticipate Accuray Incorporated (ARAY) Will Post Quarterly Sales of $108.45 Million Analysts Anticipate Accuray Incorporated (ARAY) Will Post Quarterly Sales of $108.45 Million
www.americanbankingnews.com - May 6 at 2:40 AM
Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing RulesAccuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
finance.yahoo.com - May 5 at 9:21 AM
Zacks: Analysts Anticipate Accuray Incorporated (ARAY) Will Post Earnings of -$0.02 Per ShareZacks: Analysts Anticipate Accuray Incorporated (ARAY) Will Post Earnings of -$0.02 Per Share
www.americanbankingnews.com - May 4 at 5:21 PM
Accuray (ARAY) Downgraded by BidaskClubAccuray (ARAY) Downgraded by BidaskClub
www.americanbankingnews.com - May 3 at 11:21 PM
FY2018 Earnings Forecast for Accuray Incorporated (ARAY) Issued By Jefferies GroupFY2018 Earnings Forecast for Accuray Incorporated (ARAY) Issued By Jefferies Group
www.americanbankingnews.com - May 3 at 9:52 AM
Accuray Moves Back From A Spark To A Damp SquibAccuray Moves Back From A Spark To A Damp Squib
seekingalpha.com - May 1 at 4:41 PM
BRIEF-Accuray Q3 Loss Per Share $0.10BRIEF-Accuray Q3 Loss Per Share $0.10
www.reuters.com - May 1 at 9:07 AM
Accurays (ARAY) CEO Josh Levine on Q3 2018 Results - Earnings Call TranscriptAccuray's (ARAY) CEO Josh Levine on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - May 1 at 9:07 AM
Edited Transcript of ARAY earnings conference call or presentation 30-Apr-18 8:30pm GMTEdited Transcript of ARAY earnings conference call or presentation 30-Apr-18 8:30pm GMT
finance.yahoo.com - May 1 at 9:07 AM
Accuray (ARAY) Announces Quarterly  Earnings ResultsAccuray (ARAY) Announces Quarterly Earnings Results
www.americanbankingnews.com - April 30 at 7:08 PM
Accuray Reports Third Fiscal Quarter ResultsAccuray Reports Third Fiscal Quarter Results
finance.yahoo.com - April 30 at 4:43 PM
Accuray: Fiscal 3Q Earnings SnapshotAccuray: Fiscal 3Q Earnings Snapshot
finance.yahoo.com - April 30 at 4:43 PM
Accuray (ARAY) Upgraded to Hold at BidaskClubAccuray (ARAY) Upgraded to Hold at BidaskClub
www.americanbankingnews.com - April 26 at 1:31 PM
South Florida Radiation Oncology Treats First Cancer Patients Using Its New CyberKnife® M6™ SystemSouth Florida Radiation Oncology Treats First Cancer Patients Using Its New CyberKnife® M6™ System
www.prnewswire.com - April 24 at 9:02 AM
 Analysts Expect Accuray Incorporated (ARAY) Will Announce Quarterly Sales of $98.18 Million Analysts Expect Accuray Incorporated (ARAY) Will Announce Quarterly Sales of $98.18 Million
www.americanbankingnews.com - April 19 at 2:50 AM
Accuray Incorporated (ARAY) Given Consensus Recommendation of "Hold" by BrokeragesAccuray Incorporated (ARAY) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 18 at 9:14 AM
Accuray (ARAY) to Release Quarterly Earnings on WednesdayAccuray (ARAY) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 1:52 AM
Accuray (ARAY) Rating Increased to Hold at Zacks Investment ResearchAccuray (ARAY) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - April 17 at 10:55 PM
Zacks: Brokerages Expect Accuray Incorporated (ARAY) Will Announce Earnings of -$0.03 Per ShareZacks: Brokerages Expect Accuray Incorporated (ARAY) Will Announce Earnings of -$0.03 Per Share
www.americanbankingnews.com - April 17 at 3:19 PM
Accuray amène les patients au cœur des innovations dans le traitement du cancer à lESTRO 37Accuray amène les patients au cœur des innovations dans le traitement du cancer à l'ESTRO 37
www.prnewswire.com - April 17 at 7:49 AM
Accuray (ARAY) Rating Lowered to Strong Sell at Zacks Investment ResearchAccuray (ARAY) Rating Lowered to Strong Sell at Zacks Investment Research
www.americanbankingnews.com - April 16 at 9:17 PM
Accuray (ARAY) Cut to "Sell" at BidaskClubAccuray (ARAY) Cut to "Sell" at BidaskClub
www.americanbankingnews.com - April 15 at 2:21 PM
Royal Bank of Canada Reiterates "$6.00" Price Target for Accuray (ARAY)Royal Bank of Canada Reiterates "$6.00" Price Target for Accuray (ARAY)
www.americanbankingnews.com - April 10 at 12:30 PM
Accuray To Report Fiscal 2018 Third Quarter Financial Results On April 30, 2018Accuray To Report Fiscal 2018 Third Quarter Financial Results On April 30, 2018
finance.yahoo.com - April 9 at 9:15 AM
BidaskClub Downgrades Accuray (ARAY) to SellBidaskClub Downgrades Accuray (ARAY) to Sell
www.americanbankingnews.com - April 5 at 10:26 AM
Accuray (ARAY) Earns Buy Rating from CowenAccuray (ARAY) Earns Buy Rating from Cowen
www.americanbankingnews.com - April 4 at 5:52 PM
Alaleh Nouri Sells 2,585 Shares of Accuray Incorporated (ARAY) StockAlaleh Nouri Sells 2,585 Shares of Accuray Incorporated (ARAY) Stock
www.americanbankingnews.com - April 3 at 11:05 PM
Accuray Incorporated (ARAY) CFO Sells $13,936.05 in StockAccuray Incorporated (ARAY) CFO Sells $13,936.05 in Stock
www.americanbankingnews.com - April 3 at 11:04 PM
Joshua Levine Sells 8,675 Shares of Accuray Incorporated (ARAY) StockJoshua Levine Sells 8,675 Shares of Accuray Incorporated (ARAY) Stock
www.americanbankingnews.com - April 3 at 10:44 PM
$98.18 Million in Sales Expected for Accuray Incorporated (ARAY) This Quarter$98.18 Million in Sales Expected for Accuray Incorporated (ARAY) This Quarter
www.americanbankingnews.com - April 2 at 2:48 AM
Accuray Incorporated (ARAY) Expected to Post Earnings of -$0.03 Per ShareAccuray Incorporated (ARAY) Expected to Post Earnings of -$0.03 Per Share
www.americanbankingnews.com - March 31 at 3:14 PM
Accuray Radixact Picked by India's Apollo for Cancer TreatmentAccuray Radixact Picked by India's Apollo for Cancer Treatment
finance.yahoo.com - March 29 at 4:47 PM
Accuray Radixact Picked by Indias Apollo for Cancer TreatmentAccuray Radixact Picked by India's Apollo for Cancer Treatment
www.zacks.com - March 29 at 9:24 AM
Accuray Banks on Acquisition & Partnership Amid CompetitionAccuray Banks on Acquisition & Partnership Amid Competition
www.zacks.com - March 28 at 9:19 AM
Apollo Hospitals in India to Acquire Two Accuray Radixact® SystemsApollo Hospitals in India to Acquire Two Accuray Radixact® Systems
www.prnewswire.com - March 28 at 7:51 AM
Accuray (ARAY) Stock Rating Lowered by Zacks Investment ResearchAccuray (ARAY) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - March 27 at 1:51 PM
Erasmus MC Completes First Step in the Evolution of Online Adaptive Radiation Therapy with the CyberKnife® SystemErasmus MC Completes First Step in the Evolution of Online Adaptive Radiation Therapy with the CyberKnife® System
finance.yahoo.com - March 27 at 9:26 AM
Accuray Incorporated (ARAY) Receives Consensus Recommendation of "Hold" from AnalystsAccuray Incorporated (ARAY) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 24 at 8:10 AM
Technical Perspectives on Medical Equipment Stocks -- Accuray, AcelRx Pharma, Aethlon Medical, and CHF SolutionsTechnical Perspectives on Medical Equipment Stocks -- Accuray, AcelRx Pharma, Aethlon Medical, and CHF Solutions
www.bizjournals.com - March 20 at 9:18 AM
Zacks: Brokerages Anticipate Accuray Incorporated (ARAY) to Announce -$0.03 EPSZacks: Brokerages Anticipate Accuray Incorporated (ARAY) to Announce -$0.03 EPS
www.americanbankingnews.com - March 14 at 2:53 PM
Accuray Gains on Radixact Unit, Solid Geographical Foothold - NasdaqAccuray Gains on Radixact Unit, Solid Geographical Foothold - Nasdaq
www.nasdaq.com - March 14 at 9:54 AM

SEC Filings

Accuray (NASDAQ:ARAY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Accuray (NASDAQ:ARAY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Accuray (NASDAQ ARAY) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.